Showing results (61-70 of 610) with videos related to
Sort By:
Pageof 61
Bailliere'S Clinical Haematology|June 1, 1995
New thrombolytic agents and strategiesD Collen, H R LijnenThrombosis and Haemostasis|July 1, 1995
Molecular basis of fibrinolysis, as relevant for thrombolytic therapyD Collen, H R LijnenArteriosclerosis (Dallas, Tex.)|November 1, 1984
New approaches to thrombolytic therapyD Collen, H R LijnenThrombosis and Haemostasis|February 3, 1992
Biochemical and biological properties of a recombinant tissue-type plasminogen activator derived from the rat JMI-229 cell lineH R Lijnen, P D Webb, B Van Hoef, et al.Thrombosis and Haemostasis|May 11, 1999
Structural and functional basis of plasminogen activation by staphylokinaseL Jespers, S Vanwetswinkel, H R Lijnen, et al.Biochemical and Biophysical Research Communications|November 22, 2008
Deficiency of vascular endothelial growth factor-D does not affect murine adipose tissue developmentH R Lijnen, L Frederix, B Van Hoef, et al.European Journal of Biochemistry|December 15, 1992
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinaseP Holvoet, Y Laroche, H R Lijnen, et al.Blood|May 1, 1986
A monoclonal antibody preventing binding of tissue-type plasminogen activator to fibrin: useful to monitor fibrinogen breakdown during t-PA infusionP Holvoet, H R Lijnen, D CollenCirculation Research|May 4, 2002
Reduced atherosclerotic plaque but enhanced aneurysm formation in mice with inactivation of the tissue inhibitor of metalloproteinase-1 (TIMP-1) geneJ Silence, D Collen, H R LijnenPageof 61